Ipca Labs arm acquires 80% stake in US-based Bayshore Pharma for $10.286 mn

The acquisition of a majority stake in Bayshore will allow Ipca to commercialise its registered generic drug products in the US market

from Latest News https://ift.tt/2xXBbwm
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share